会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明公开
    • 시트레오로세인을 함유하는 대사성질환 예방 및 치료용 조성물
    • 用于预防和治疗含有CITREOROSEIN的代谢综合征的组合物
    • KR1020130074152A
    • 2013-07-04
    • KR1020110142047
    • 2011-12-26
    • 영남대학교 산학협력단
    • 장현욱손종근황승락정용태
    • A61K31/122A61P3/04A61P3/10A61P3/00
    • PURPOSE: A composition containing citreorosein for preventing and treating metabolic syndrome is provided to ensure stable treatment effect without side effects and to be used as a pharmaceutical composition and a health food composition. CONSTITUTION: A composition for preventing or treating metabolic syndrome contains citreorosein. The metabolic syndrome is selected from the group consisting of hypertriglyceridemia, obesity, hypertension, arteriosclerosis, hyperlipidemia, liver diseases, hyperinsulinemia, hyperglycermia, diabetes, and insulin resistance disorder. The diabetes is type 2 diabetes. Citreorosein activates LKB1 (liver kinase B1) and increases glucose uptake in a cell by activated AMPK (AMP-activated protein kinase). A pharmaceutical composition for preventing or treating metabolic syndrome contains citreorosein. A health food composition for preventing or treating metabolic syndrome contains citreorosein.
    • 目的:提供含有柠檬香草素预防和治疗代谢综合征的组合物,以确保稳定的治疗效果而无副作用,并用作药物组合物和保健食品组合物。 构成:用于预防或治疗代谢综合征的组合物含有柠檬香豆素。 代谢综合征选自高甘油三酯血症,肥胖症,高血压,动脉硬化,高脂血症,肝脏疾病,高胰岛素血症,高糖,糖尿病和胰岛素抵抗障碍。 糖尿病是2型糖尿病。 柠檬酸激活LKB1(肝激酶B1),并通过活化的AMPK(AMP激活的蛋白激酶)增加细胞中的葡萄糖摄取。 用于预防或治疗代谢综合征的药物组合物含有柠檬香豆素。 用于预防或治疗代谢综合征的保健食品组合物含有柠檬香豆素。
    • 26. 发明授权
    • 삼백초 추출물 또는 이로부터 분리된 화합물을유효성분으로 함유하는 미백용 조성물
    • 包含SAURURUS CHINENSIS萃取物或其分离的化合物的组合物,用于皮肤白化
    • KR100865071B1
    • 2008-10-23
    • KR1020070041266
    • 2007-04-27
    • 영남대학교 산학협력단
    • 이승호손종근김영수장영동
    • A61K8/97A61Q19/02
    • A61K8/97A61K36/78A61Q19/02Y10S514/844
    • A composition comprising the extract of Saururus chinensis or compounds isolated therefrom is provided to inhibit biosynthesis of melanin by inhibiting activity of tyrosinase without side effects, so that the composition is useful for skin whitening. A pharmaceutical or cosmetic composition for skin whitening comprises 0.1-50 wt.% of the extract of Saururus chinensis which is prepared by extracting root, stem or leaf of Saururus chinensis with water, C1-C4 lower alcohol, propylene glycol, ethyl acetate, butylene glycol, ether or chloroform; or compounds isolated therefrom including saucerneol B represented by the formula(1), manassantin B represented by the formula(2), and manassantin A represented by the formula(3) which are obtained by fractionating the crude extract of Saururus chinensis with hexane, ethylacetate or butanol, and subjecting the fraction to column chromatography.
    • 提供一种组合物,其中含有中华黄牛提取物或从其中分离的化合物,通过抑制酪氨酸酶的活性而无副作用来抑制黑色素的生物合成,因此该组合物可用于皮肤美白。 一种用于皮肤美白的药物或化妆品组合物,其含有0.1-50重量%的中华黄瓜提取物,其通过用水,C1-C4低级醇,丙二醇,乙酸乙酯,丁烯萃取中华黄瓜的根,茎或叶 乙二醇,乙醚或氯仿; 或由其分离的化合物,包括由式(1)表示的沙美奈酚B,由式(2)表示的马桑丁汀B和由式(3)表示的马萨固丁A,其通过用己烷,乙酸乙酯 或丁醇,并对馏分进行柱层析。
    • 27. 发明公开
    • 단삼 추출물을 유효성분으로 함유하는 천식 및 알러지성질환의 예방 및 치료용 조성물.
    • 包含SALVIA ​​MILTIORRHIZA BUNGE提取物用于预防和治疗哮喘和过敏性疾病的组合物
    • KR1020080023570A
    • 2008-03-14
    • KR1020060087608
    • 2006-09-11
    • 영남대학교 산학협력단
    • 장현욱손종근이승호손건호남경수김철호
    • A61K36/537A61P37/08
    • A61K36/537A23V2200/304A23V2200/314A61K2236/331A61K2236/333A61K2236/35Y10S514/826
    • A composition comprising the extract of Salvia miltiorrhiza BUNGE is provided to inhibit production of leukotriene C4(LTC4) depending on 5-LOX(5-lipoxygenase), production of prostaglandin D2(PGD2) depending on COX-2(cyclooxygenase-2), and degranulation in mast cells, so that the composition is useful for prevention and treatment of asthma and allergic disease. A composition for prevention and treatment of asthma and allergic disease including bronchial asthma, allergic rhinitis, allergic asthma and allergic dermatitis comprises the crude extract of Salvia miltiorrhiza BUNGE which is prepared with water, C1-C4 lower alcohol or a mixed solvent thereof, the polar solvent extract of Salvia miltiorrhiza BUNGE which is prepared with water, methanol, ethanol, butanol or a mixed solvent thereof, or the non-polar solvent extract of Salvia miltiorrhiza BUNGE which is prepared with hexane, chloroform or ethylacetate, and is a pharmaceutical or health food composition having a formulation of powder, granule, tablet, capsule or drink.
    • 提供包含丹参提取物BUNGE的组合物以抑制依赖于5-LOX(5-脂氧合酶),依赖于COX-2(环氧合酶-2)的前列腺素D2(PGD2)的产生而产生白细胞三烯C4(LTC4) 在肥大细胞中脱颗粒,使得该组合物可用于预防和治疗哮喘和过敏性疾病。 用于预防和治疗哮喘和过敏性疾病(包括支气管哮喘,过敏性鼻炎,过敏性哮喘和过敏性皮炎)的组合物包括用水,C1-C4低级醇或其混合溶剂制备的丹参BUNGE的粗提物,极性 用水,甲醇,乙醇,丁醇或其混合溶剂制备的丹参溶剂提取物,或用己烷,氯仿或乙酸乙酯制备的丹参丹参的非极性溶剂提取物,是药物或健康 具有粉末,颗粒,片剂,胶囊或饮料制剂的食品组合物。
    • 28. 发明授权
    • 삼백초 추출물에서 분리된 사우세르네올 B 화합물을함유하는 염증, 알러지 및 천식 질환의 예방 및 치료용조성물
    • 삼백초삼백초물물물물분분분분된사사사올올올올올올염증염증알러알러알러알러알러알러및및및및및및물물물물물물물물물물물물물물
    • KR100739399B1
    • 2007-07-13
    • KR1020060031375
    • 2006-04-06
    • 영남대학교 산학협력단
    • 장현욱손종근강삼식배기환김현표손건호
    • A61K31/36A61P29/00A61P37/00A61P11/06
    • A composition for the prevention and treatment of inflammatory, allergy or asthma diseases comprising saucerneol B isolated from Saururus chinensis is provided to inhibit 5-lipoxygenase activity, production of cyclooxygenase-2 dependent prostaglandin D2, degranulation in a mast cell, production of nitric oxide radical, expression of iNOS(inducible nitric oxide synthase) and activity of MMP-9(matrix metalloproteinase-9), and to reduce side effects due to its low toxicity. The composition for the prevention and treatment of inflammatory, allergy or asthma diseases comprises 0.01-99.9%, preferably 0.1-90% of the saucerneol B isolated from Saururus chinensis and represented by the formula(1), wherein the saucerneol B is prepared by cutting dried roots, leaves or stems of Saururus chinensis, extracting the fragments of Saururus chinensis with a solvent selected from water, C1-C4 lower alcohol such as methanol at 20-30 deg.C for 1 hour to 10 days, filtering and concentrating the extract of Saururus chinensis under reduced pressure, fractionating the Saururus chinensis extract with n-hexane, ethylacetate, n-butanol and water, sequentially, and subjecting the fraction to chromatography. The daily dosage of the saucerneol B is 0.0001-100 mg/kg.
    • 提供了一种用于预防和治疗炎症,变态反应或哮喘疾病的组合物,其包含从Saururus chinensis分离的索诺酚B以抑制5-脂氧合酶活性,产生环加氧酶-2依赖性前列腺素D2,在肥大细胞中脱粒,产生一氧化氮自由基 ,iNOS(诱导型一氧化氮合酶)的表达和MMP-9(基质金属蛋白酶-9)的活性,并且由于其低毒性而减少副作用。 用于预防和治疗炎症,变态反应或哮喘疾病的组合物包含0.01-99.9%,优选0.1-90%的从Saururus chinensis分离的并且由式(1)表示的松香醇B,其中所述松香醇B通过切割 三白草的干燥根,叶或茎,用选自水,C 1 -C 4低级醇如甲醇的溶剂在20-30℃下提取三白草的片段1小时至10天,过滤并浓缩提取物 的三白草在减压下,依次用正己烷,乙酸乙酯,正丁醇和水分离三白草提取物,并将该部分进行色谱分离。 松香醇B的日剂量为0.0001-100mg / kg。